Therapeutics for Inpatients with COVID-19 (TICO) : A Multicentre, Adaptive, Randomised, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeuticsfor Hospitalised Patients with COVID-19Short Title: Therapeutics for Inpatients with COVID-19 (TICO)INSIGHT Protocol Number: 014 / ACTIV-3 - Therapeutics for Inpatients with COVID-19 (TICO)
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
WHO International Clinical Trials Registry Platform - (2022) vom: 08. Aug. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 05-01-2021, Last updated: 2022-11-24 |
|---|
| ICTRP ID: |
EUCTR2020-003278-37-GR |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
CTG00758492X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG00758492X | ||
| 003 | DE-627 | ||
| 005 | 20230425173322.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210512s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)CTG00758492X | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)EUCTR2020-003278-37-GR | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)INSIGHT014 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)NCT04501978 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)2020-003278-37-DK | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Therapeutics for Inpatients with COVID-19 (TICO) |b A Multicentre, Adaptive, Randomised, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeuticsfor Hospitalised Patients with COVID-19Short Title: Therapeutics for Inpatients with COVID-19 (TICO)INSIGHT Protocol Number: 014 / ACTIV-3 - Therapeutics for Inpatients with COVID-19 (TICO) |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 05-01-2021, Last updated: 2022-11-24 | ||
| 650 | 4 | |a Medical Condition: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02] | |
| 650 | 4 | |a Study Type: Interventional | |
| 650 | 4 | |a Phase: Phase 3 | |
| 650 | 4 | |a Recruitment Status: Authorised-recruitment may be ongoing or finished | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t WHO International Clinical Trials Registry Platform |g (2022) vom: 08. Aug. |
| 773 | 1 | 8 | |g year:2022 |g day:08 |g month:08 |
| 856 | 4 | 0 | |u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003278-37 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 08 |c 08 | ||